ITEOS THERAPEUTICS, INC – Trademark Portfolio
Entity Type: 03
ITEOS THERAPEUTICS, INC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ITEOS and CANCER IMMUNOTHERAPIES BY DESIGN. The owner is based in Cambridge, MA.
139 Main Street
Cambridge, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
ITEOS THERAPEUTICS, INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ITEOS THERAPEUTICS, INC have?
ITEOS THERAPEUTICS, INC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does ITEOS THERAPEUTICS, INC file in?
ITEOS THERAPEUTICS, INC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ITEOS THERAPEUTICS, INC's most well-known trademarks?
ITEOS THERAPEUTICS, INC's registered trademark portfolio includes well-known marks such as ITEOS and CANCER IMMUNOTHERAPIES BY DESIGN. These are among 3 currently registered trademarks in the portfolio.
What is ITEOS THERAPEUTICS, INC's trademark registration success rate?
ITEOS THERAPEUTICS, INC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.